Skip to content

Share Buybacks at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$2B
Globus Medical logo
Globus MedicalGMED
$0-100%
MiMedx Group logo
MiMedx GroupMDXG
$0
AbbVie logo
AbbVieABBV
$1.49B+54.9%
Medtronic logo
MedtronicMDT
$435M+58.8%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
$6.37M

Other financials

Income statement

See full
Revenue$418.8M+0.8%
Gross profit$219.7M+5.0%
Operating income$19.3M+104%
Net income$4.5M+101%
EPS (diluted)$0.06+101%

Balance sheet

See full
Cash & equivalents$214.4M-1.6%
Total debt$2.0B+3.2%
Total equity$1.0B+0.5%
Total assets$3.6B-2.8%

Cash flow

See full
Operating cash flow$22.8M+156%
CapEx$12.3M-38.9%
Free cash flow$10.5M+193%

Valuation

See full
Market cap$1.54B+53.8%
Enterprise value$3.29B+22.4%
P/S0.9×+0.3×

Profitability

See full
Gross margin52.5%-0.1pp
Operating margin2.6%+1.3pp
Net margin-0.4%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-0.7%
Debt / equity1.9×+0.1×
Current ratio3.6×+2.4×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Integra LifeSciences’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's share buybacks?
Integra LifeSciences (IART) reported share buybacks of $55.25K in Q4 2025.
How has Integra LifeSciences's share buybacks changed year-over-year?
Integra LifeSciences's share buybacks decreased by 97.8% year-over-year, from $2.47M to $55.25K.
What does share buybacks mean?
Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.